CHE · NYSE
Chemed (CHE) Stock Price & Fundamentals
Chemed (CHE) closed at $287.71 on Oct 9, 2026, up 0.08% from the previous close of $287.49.
Share price, past year
1Y +0.52%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $287.71 |
| Sep 30, 2026 | $284.41 |
| Aug 31, 2026 | $292.39 |
| Jul 31, 2026 | $276.08 |
| Jun 30, 2026 | $280.88 |
| May 29, 2026 | $287.78 |
| Apr 30, 2026 | $292.79 |
| Mar 31, 2026 | $265.47 |
| Feb 27, 2026 | $267.21 |
| Jan 30, 2026 | $268.61 |
| Dec 31, 2025 | $254.74 |
| Nov 28, 2025 | $274.79 |
| Oct 31, 2025 | $290.87 |
Key statistics
- Market cap
- $3.76B
- P/E (TTM)
- 14.5
- EPS (TTM)
- $19.88
- Revenue (TTM)
- $2.60B
- Net income (TTM)
- $274.99M
- Shares outstanding
- 13.1M
- Dividend yield
- —
- 52-week range
- $252.35 – $297.21
Chemed's market cap is $3.76B, based on a share price of $287.71 and 13.1M shares outstanding as of Jun 30, 2026.
Financials
Chemed reported revenue of $2.53B for fiscal 2025, up 4.06% from fiscal 2024.
Chemed earned net income of $265.24M in fiscal 2025, a net margin of 10.5%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $2.53B | +4.1% | $265.24M | 10.5% | $18.34 | $325.48M |
| FY2024ended Dec 31, 2024 | $2.43B | +7.4% | $302.00M | 12.4% | $19.89 | $367.97M |
| FY2023ended Dec 31, 2023 | $2.26B | +6.1% | $272.51M | 12.0% | $17.93 | $273.45M |
| FY2022ended Dec 31, 2022 | $2.13B | −0.2% | $249.62M | 11.7% | $16.53 | $252.56M |
| FY2021ended Dec 31, 2021 | $2.14B | +2.9% | $268.55M | 12.6% | $16.85 | $249.92M |
| FY2020ended Dec 31, 2020 | $2.08B | +7.3% | $319.47M | 15.4% | $19.48 | $430.46M |
| FY2019ended Dec 31, 2019 | $1.94B | +8.8% | $219.92M | 11.3% | $13.31 | $248.23M |
| FY2018ended Dec 31, 2018 | $1.78B | +7.0% | $205.54M | 11.5% | $12.23 | $234.27M |
| FY2017ended Dec 31, 2017 | $1.67B | +5.7% | $98.18M | 5.9% | $5.86 | $98.20M |
| FY2016ended Dec 31, 2016 | $1.58B | — | $108.74M | 6.9% | $6.48 | $95.62M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $673.25M | $67.70M | $5.13 |
| Q1 FY2026ended Mar 31, 2026 | $657.51M | $66.30M | $4.84 |
| Q4 FY2025ended Dec 31, 2025 | $639.34M | $76.75M | $5.45 |
| Q3 FY2025ended Sep 30, 2025 | $624.90M | $64.24M | $4.46 |
| Q2 FY2025ended Jun 30, 2025 | $618.80M | $52.49M | $3.57 |
| Q1 FY2025ended Mar 31, 2025 | $646.94M | $71.76M | $4.86 |
| Q4 FY2024ended Dec 31, 2024 | $639.99M | $90.32M | $6.00 |
| Q3 FY2024ended Sep 30, 2024 | $606.18M | $75.78M | $5.00 |
Company profile
- Name
- Chemed Corp
- Ticker
- CHE
- Exchange
- NYSE
- Industry (SEC SIC)
- Services-Home Health Care Services
- Headquarters
- Suite 2600, 255 E Fifth St, Cincinnati, OH 45202
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000019584
Recent SEC filings
- Jul 31, 2026
- Jul 28, 2026
- May 19, 2026
- Apr 28, 2026
- Apr 23, 2026
- Apr 13, 2026
- Feb 27, 2026
- Feb 25, 2026
Frequently asked questions
What is Chemed's stock price?
Chemed (CHE) closed at $287.71 on Oct 9, 2026, up 0.08% from the previous close of $287.49.
What is Chemed's market cap?
Chemed's market cap is $3.76B, based on a share price of $287.71 and 13.1M shares outstanding as of Jun 30, 2026.
How much revenue does Chemed make?
Chemed reported revenue of $2.53B for fiscal 2025, up 4.06% from fiscal 2024.
What is CHE's P/E ratio?
Chemed's price-to-earnings ratio is 14.5, based on trailing twelve-month diluted EPS of $19.88.
Does Chemed pay a dividend?
Chemed's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Chemed Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures